Not Tagged
Not Tagged
[]
general observation from #gi23: when it comes to clinical trial design merging with excitement of immunotherapies, pushing forward w/trials in pts without preclinical data or firm rationales for sequencing of therapies (rt, chemo) with io can be an ineffective use of resources.
Physician-Scientist/Clinical Cancer Biologist. Clinical focus: GI Cancers/Neuro-Oncology. In lab: #TunnelingNanotubes and other drivers of La ChemoResistance